免責聲明: 本站彙整 FDA、ClinicalTrials.gov、PubMed、SEC EDGAR 等官方公開資料,僅供一般參考,不構成醫療建議、診斷、治療建議或投資建議。

臨床試驗

Zephyr Valve Japan Post-Marketing Surveillance

NCT:NCT06332885 · RECRUITING

NCT IDNCT06332885
狀態RECRUITING
開始日期2024-03-12
完成時間2028-03-31
SponsorPulmonx Corporation (INDUSTRY)
First posted
Last updated

簡要摘要

This is a multicenter, prospective, observational surveillance enrolling 140 consecutive patients with severe emphysema who are candidates for bronchoscopic lung volume reduction using Zephyr Endobronchial Valve at up to 20 centers across Japan and followed for 12 months.

官方來源

在 ClinicalTrials.gov 上查看 →

資料來自 ClinicalTrials.gov API。最新狀態請參閱官方紀錄。

↑